Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.

作者: Charles P. Denaro , Neal L. Benowitz

DOI: 10.1007/BF03259923

关键词:

摘要: Since most of the toxicity associated with class 1B antiarrhythmic drugs is dose-related, this review examines adverse effects seen in both therapeutic practice and accidental or premeditated overdose. Toxicity very common these agents can be life-threatening. A high percentage patients must discontinue therapy because effects. Mexiletine tocainide are structural analogues lignocaine (lidocaine) similar all 3 drugs. With gradual intoxication (the form) central nervous system such as lightheadedness, dizziness, drowsiness confusion first. Seizures respiratory arrest occur. Cardiovascular manifested by progressive heart block, reduced cardiac contraction, hypotension asystole. Both mexiletine may have proarrhythmic Gastrointestinal also common. Shock, hypotension, failure beta-blocker reduce clearance enhance risk during routine therapy. elimination impaired severe liver disease while renal failure. Management largely supportive symptomatic. Lignocaine infusion discontinued decontamination gut case oral preparations recommended. Serious requires intensive care unit admission. Haemodialysis haemoperfusion helpful serious poisoning. In institutions where extracorporeal circulatory assistance available, massive poisoning has been successfully treated intervention. setting prevented close clinical surveillance appropriate dose reduction drug clearance. Because large interindividual variation pharmacokinetic parameters, monitoring recommended if results reported quickly. stereoselective metabolism assays do not distinguish more active isomers. Therapeutic less useful situation.

参考文章(103)
Hillel Halkin, Peter Meffin, Kenneth L. Melmon, Malcolm Rowland, Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metabolite Clinical Pharmacology & Therapeutics. ,vol. 17, pp. 669- 676 ,(1975) , 10.1002/CPT1975176669
John M. Strong, Douglas E. Mayfield, Arthur J. Atkinson, B. Cullen Burris, Frank Raymon, Leslie T. Webster, Pharmacological activity, metabolism, and pharmacokinetics of glycinexylidide. Clinical Pharmacology & Therapeutics. ,vol. 17, pp. 184- 194 ,(1975) , 10.1002/CPT1975172184
Michael A. Peat, Mary E. Deyman, Dennis J. Crouch, Pierre Margot, Bryan S. Finkle, Concentrations of lidocaine and monoethylglycylxylidide (MEGX) in lidocaine associated deaths. Journal of Forensic Sciences. ,vol. 30, pp. 1048- 1057 ,(1985) , 10.1520/JFS11045J
Ken A. Collinsworth, John M. Strong, Arthur J. Atkinson, Roger A. Winkle, Frank Perlroth, Donald C. Harrison, Pharmacokinetics and metabolism of lidocaine in patients with renal failure. Clinical Pharmacology & Therapeutics. ,vol. 18, pp. 59- 64 ,(1975) , 10.1002/CPT197518159
Neal Benowitz, Ralph P. Forsyth, Kenneth L. Melmon, Malcolm Rowland, Lidocaine disposition kinetics in monkey and man; I. Prediction by a perfusion model Clinical Pharmacology & Therapeutics. ,vol. 16, pp. 87- 98 ,(1974) , 10.1002/CPT1974161PART187
Jeffrey J. Pomerance, Alvin A. Miller, Wesley Y. Kim, Lidocaine intoxication in a newborn following local anesthesia for episiotomy. Pediatrics. ,vol. 64, pp. 643- 645 ,(1979)
Henry J. Pfeifer, David J. Greenblatt, Jan Koch-Weser, Clinical use and toxicity of intravenous lidocaine American Heart Journal. ,vol. 92, pp. 168- 173 ,(1976) , 10.1016/S0002-8703(76)80252-9
Robert J. Luchi, John Helwig, Hadley L. Conn, Quinidine toxicity and its treatment. An Experimental study. American Heart Journal. ,vol. 65, pp. 340- 348 ,(1963) , 10.1016/0002-8703(63)90008-5
Kris Sperry, Nancy Wohlenberg, Jim C. Standefer, Fatal Intoxication by Tocainide Journal of Forensic Sciences. ,vol. 32, pp. 11193J- 1446 ,(1987) , 10.1520/JFS11193J
Alphonse Poklis, Mary A. Mackell, Eugene F. Tucker, Tissue distribution of lidocaine after fatal accidental injection. Journal of Forensic Sciences. ,vol. 29, pp. 1229- 1236 ,(1984) , 10.1520/JFS11794J